Literature DB >> 1352246

Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteers.

M Beneke1, W Wingender, R Horstmann, I Konrad-Dalhoff, H Weber, J Kuhlmann, B H Schmidt.   

Abstract

The neuroendocrine effects (changes in plasma CRF, ACTH and cortisol) of single and multiple (t.d.s. for 2 days) doses of ipsapirone (BAY Q 7821) 5 and 10 mg have been investigated in 6 healthy male volunteers. The study followed a balanced complete block, placebo-controlled and double blind design with two baseline phases (pre and post-treatment). Volunteers were investigated on identical days during 5 successive weeks. The results do not show a specific effect of ipsapirone on the hypothalamic-pituitary-adrenal axis when doses in the range of 5-30 mg per day were given.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352246     DOI: 10.1007/bf00278478

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

Review 1.  Neuropharmacologic control of neuroendocrine function in man.

Authors:  L A Frohman; M E Stachura
Journal:  Metabolism       Date:  1975-02       Impact factor: 8.694

2.  Effect on various putative neurotransmitters on the secretion of corticotrophin-releasing hormone from the rat hypothalamus in vitro-a model of the neurotransmitters involved.

Authors:  M T Jones; E W Hillhouse; J Burden
Journal:  J Endocrinol       Date:  1976-04       Impact factor: 4.286

3.  Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans.

Authors:  K P Lesch; R Rupprecht; B Poten; U Müller; K Söhnle; J Fritze; H M Schulte
Journal:  Biol Psychiatry       Date:  1989-06       Impact factor: 13.382

4.  The effects of gepirone on neuroendocrine function and temperature in humans.

Authors:  I M Anderson; P J Cowen; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Corticosteroid inhibition of ACTH secretion.

Authors:  M E Keller-Wood; M F Dallman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

6.  Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.

Authors:  J Traber; M A Davies; W U Dompert; T Glaser; T Schuurman; P R Seidel
Journal:  Brain Res Bull       Date:  1984-06       Impact factor: 4.077

7.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Synapse       Date:  1987       Impact factor: 2.562

8.  Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study.

Authors:  Z Liposits; C Phelix; W K Paull
Journal:  Histochemistry       Date:  1987

9.  Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.

Authors:  F Gilbert; C Brazell; M D Tricklebank; S M Stahl
Journal:  Eur J Pharmacol       Date:  1988-03-15       Impact factor: 4.432

10.  The effects of gepirone and 1-(2-pyrimidinyl)-piperazine on levels of corticosterone in rat plasma.

Authors:  G K Matheson; D Gage-White; G White; D Guthrie; J Rhoades; V Dixon
Journal:  Neuropharmacology       Date:  1989-04       Impact factor: 5.250

View more
  2 in total

1.  The antagonism of ipsapirone induced biobehavioral responses by +/- pindolol in high and low impulsives.

Authors:  J Hennig; C Opper; S Huwe; P Netter
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

2.  Effects of ipsapirone in healthy subjects: a dose-response study.

Authors:  R S Kahn; R Trestman; B A Lawlor; S Gabriel; M Davidson; L Siever
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.